MRNA

2025Q2BMO

Moderna Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-08-01 · Fiscal end 2025-06-30 · Features as of 2025-07-31

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-3.00
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move4.5%
IV front—
P/C full—
P/C front—
Features as of2025-07-31

Run-up

Close—
Ret 5d-13.1%
Ret 10d-8.2%
Ret 20d-2.4%
Ret 30d+15.7%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-2.13Beat
Estimated EPS-3.00
Actual revenue
142.0M
Surprise %+29.0%
Beat / missBeat
Beat streak 42
Beat streak 82

Reaction

1-day stock reaction+0.1%
Implied vs actual

Implied 4.5%Actual 6.7%

Gap reaction-6.7%
Day result-6.6%
Next-day upYes
Realized / IV1.48×

Post tape

Post 5d-5.4%
Post 10d+1.5%
Post volume16.3M
Vol ×10d2.02×
Vol ×20d1.90×
Post range4.8%